Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12 USD | -0.54% | -4.82% | -15.79% |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.79% | 220M | |
+27.72% | 426B | |
+30.15% | 276B | |
+3.22% | 135B | |
+7.05% | 92.01B | |
+25.57% | 89.16B | |
+65.64% | 58.86B | |
+10.42% | 45.03B | |
+19.19% | 34.77B | |
-11.77% | 31.93B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- B. Riley Resumes OptimizeRx at Buy With $30 PT, Notes Increased Pharma Ad Spend on Digital Channels as Key Market Tailwind